Live Chat ×
Skip to main content

2021 Calcimimetic Coverage and Reimbursement Overview



This presentation will discuss the evolution of the end-stage renal disease (ESRD) bundle, the intent of the Transitional Drug Add-On Payment Adjustment (TDAPA), the valuation and inclusion of calcimimetics as part of the bundle for 2021, and reimbursement beyond the bundle.

Sponsored by 



Presented by 

Matthew Bartlett
Director, Nephrology Coverage & Pricing

Javier Orozco
Sr. Manager, Nephrology Coverage & Pricing